Diurnal

Diurnal

Biotechnology Research

A Neurocrine Biosciences Company

About us

Founded in 2004, DIURNAL®, a NEUROCRINE BIOSCIENCES® Company, is a European, UK-headquartered specialty pharmaceutical company dedicated to developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency.

Industry
Biotechnology Research
Company size
11-50 employees
Type
Privately Held

Employees at Diurnal

Affiliated pages

Similar pages